Evolution of Therapy in Lung Cancer – 2022 Program: Targeted Therapies Forum

Experience the transformation of lung cancer treatment over the years with Dr. Alejandro Calvo. This 2022 Targeted Therapies Forum session provides an insightful examination into how first-line treatments for NSCLC have evolved, adapting to new discoveries and technological advancements.

We express our gratitude to our prestigious sponsors: #Novartis, #Janssen, #Blueprintmedicine, #TakedaOncology, #Astrazeneca, #LillyOncology, and #genentech. Their support is pivotal in continuing this essential dialogue.

To delve deeper into the vast world of cancer research and treatments, and to connect with a community dedicated to understanding and combating this disease, visit http://cancerGRACE.org/ and engage at https://cancergrace.org/forum.